Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.2101 2.89% 0.01
TTNP closed up 2.89 percent on Thursday, February 27, 2020, on 88 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical TTNP trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction 2.89%
Wide Bands Range Expansion 2.89%
Below Lower BB Weakness 2.89%
Down 3 Days in a Row Weakness 2.89%
Down 4 Days in a Row Weakness 2.89%
Lower Bollinger Band Touch Weakness 2.89%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.
Pharmaceutical Chemical Compounds Organic Compounds Parkinson's Disease Schizophrenia Morphinans Opioids Drug Rehabilitation Buprenorphine Atypical Antipsychotics Chronic Conditions Fanapt Iloperidone

Is TTNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.18
52 Week Low 0.142
Average Volume 13,734,177
200-Day Moving Average 0.59
50-Day Moving Average 0.24
20-Day Moving Average 0.24
10-Day Moving Average 0.23
Average True Range 0.03
ADX 19.97
+DI 24.67
-DI 26.99
Chandelier Exit (Long, 3 ATRs ) 0.23
Chandelier Exit (Short, 3 ATRs ) 0.28
Upper Bollinger Band 0.28
Lower Bollinger Band 0.20
Percent B (%b) 0.08
BandWidth 31.18
MACD Line -0.01
MACD Signal Line 0.00
MACD Histogram -0.0058
Fundamentals Value
Market Cap 4.46 Million
Num Shares 21.2 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -0.34
Price-to-Sales 259.08
Price-to-Book 6.11
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.26
Resistance 3 (R3) 0.26 0.24 0.25
Resistance 2 (R2) 0.24 0.22 0.24 0.25
Resistance 1 (R1) 0.22 0.22 0.23 0.23 0.25
Pivot Point 0.20 0.20 0.21 0.21 0.20
Support 1 (S1) 0.19 0.19 0.20 0.19 0.17
Support 2 (S2) 0.17 0.18 0.17 0.17
Support 3 (S3) 0.16 0.17 0.17
Support 4 (S4) 0.16